Head of Research

Dr. Jon Terrett

Mgmt Jonathan Terrett new

Dr. Terrett has been with our company since February 2017, initially as Head of Immuno-Oncology and more recently taking on the expanded role as Head of Research to include drug development and platform enhancement. Dr. Terrett has an extensive track record of translating platform technologies into clinical products at our company and at other biotech companies. He has authored several scientific publications and is named inventor on multiple patents. Dr. Terrett has a B.S. in genetics at the University of Sheffield and a Ph.D. in genetics at the University of Nottingham.

Previous Next

You are now leaving the CRISPR Therapeutics website.

CRISPR Therapeutics is not responsible for the content or availability of third-party sites.